Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
We evaluate ETFs that minimize taxes on retirement income, aiming to boost net returns while controlling tax impact on withdrawals.
23,184 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
NVIDIA CEO Jensen Huang predicts AI agents will infiltrate every function in every company, signaling a new phase for...
A sudden geopolitical flare pushes crypto and traditional markets lower. This morning minute: markets tumble, testing...
Digital land once valued like scarcity-backed cities now trades at floor-level levels. The slump spans Sandbox, Decen...
A new humanoid robot from a major player has people talking. This article breaks down what a rival with a familiar lo...
Accenture beat on earnings and bookings, but two major firms trimmed price targets as investors weigh AI’s effect on ...
Young graduates facing scarce first jobs as data show the entry-level market worst it’s unfolding despite a steadier ...
Investors weigh growth plans and political headlines as DJT faces a volatile path to profitability, with forecasts sp...
An executive sale of shares often sparks questions. This article unpacks what cheesecake factory sells $328000 means ...
Monero's XMR remains in a tight range around the mid-$180s as liquidity thins. Analysts say the trapped setup could f...
Analysts see Elon Musk's Terafab strategy as a potential catalyst for chip-equipment makers and select chip stocks, b...
Oil stays above $100 as Trump signals a potential exit from Iran policy, creating volatility and shaping the midterm ...